Navigation Links
Researchers uncover mechanisms of estrogen in promoting cell death in breast cancer

A laboratory study has uncovered new details about how estrogen can activate natural pathways that kill certain breast cancer cells or tumors. The results raise the possibility that estrogen therapy may overcome resistance to certain breast cancer hormonal therapies. The study appears in the December 7 issue of the Journal of the National Cancer Institute.

When cancer treatments such as chemotherapy or hormonal therapy fail to cause tumor regression, the cause is often a malfunction of a natural pathway called apoptosis, which breaks down cells in the body. Many breast cancer cells require estrogen for survival (called estrogen receptor–positive breast cancers), and apoptosis of such cells can be induced with treatments that block estrogen, such as tamoxifen, fulvestrant, or aromatase inhibitors. Paradoxically, some cells can become adapted to survive when deprived of estrogen and undergo apoptosis in the presence of estradiol. However, the mechanism by which estrogen promotes apoptosis is not well understood.

To try to understand how the estrogen estradiol induces apoptosis in cells, V. Craig Jordan, Ph.D., D.Sc., of the Fox Chase Cancer Center in Philadelphia, and colleagues developed a line of breast cancer cells, called MCF-7:5C, that are resistant to estrogen withdrawal and that undergo apoptosis when treated with very small concentrations of estradiol. The researchers treated MCF-7:5C cells with estradiol and fulvestrant, and they also injected the cancer cells into mice to study estradiol's influence on apoptosis in tumors.

They found that estradiol induces apoptosis by activating the so-called intrinsic apoptotic pathway. This pathway is controlled by proteins on the membrane of cell organelles called mitochondria. Estradiol increased the expression of several proteins on the membrane of cell mitochondria, led to depolarization of the mitochondrial membrane, and stimulated the release of a molecule called cytochrome c int o the cell's interior, where it could activate several cellular enzymes, called caspases, which in turn initiate cell degradation. They also found that estradiol caused complete tumor regression in mice that had been injected with the MCF-7:5C breast cancer cells.

"These laboratory data have important clinical implications, particularly for the use of aromatase inhibitors as long-term therapy," write the authors, "and they suggest that, if and when resistance to aromatase inhibition occurs, a strategy of treatment with estrogen ?may be sufficient to kill the cancer and control disease progression."


'"/>

Source:Journal of the National Cancer Institute


Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ... for financial services, but it also plays a fundamental part ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):
(Date:5/23/2016)... and LONDON , May 23, 2016 ... Could See Frontage Boost Efficiency by 40% - Frontage ... - Frontage Enforce Quality, Compliance and Traceability Within the Bioanalytical ... with labs in the United States and ... to be deployed across its laboratory facilities. In addition to ...
(Date:5/23/2016)... ... 23, 2016 , ... Foresight Institute , a leading ... for the 2015 Foresight Institute Feynman Prizes. , These prestigious prizes, named ... for experiment and the other for theory in nanotechnology. Prof. Markus J. Buehler, ...
(Date:5/20/2016)... CA (PRWEB) , ... May 20, 2016 , ... The ... 10 of its most experienced veterinary clients have treated over 100 of their own ... edge technology to provide the highest level of care for their patients. , ...
(Date:5/20/2016)... NC (PRWEB) , ... May 20, 2016 , ... Korean ... suggesting that it may offer a new way to treat the disease. Surviving Mesothelioma ... it now. , Scientists from several Korean institutions based their mesothelioma study on ...
Breaking Biology Technology: